FSDPX
Price
$103.92
Change
+$1.61 (+1.57%)
Updated
Jun 2 closing price
Net Assets
823.57M
ICBAX
Price
$21.76
Change
+$0.37 (+1.73%)
Updated
Jun 2 closing price
Net Assets
140.1M
Interact to see
Advertisement

FSDPX vs ICBAX

Header iconFSDPX vs ICBAX Comparison
Open Charts FSDPX vs ICBAXBanner chart's image
FSDPX vs ICBAX Comparison Chart in %
View a ticker or compare two or three
VS
FSDPX vs. ICBAX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSDPX is a Hold and ICBAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSDPX has more cash in the bank: 824M vs. ICBAX (140M). FSDPX pays higher dividends than ICBAX: FSDPX (1.30) vs ICBAX (0.72). FSDPX was incepted earlier than ICBAX: FSDPX (40 years) vs ICBAX (16 years). ICBAX (1.56) is less costly to investors than FSDPX (0.69). ICBAX is a more actively managed with annual turnover of: 154.00 vs. FSDPX (56.00). FSDPX has a lower initial minimum investment than ICBAX: FSDPX (0) vs ICBAX (1000). ICBAX annual gain was more profitable for investors over the last year : 38.80 vs. FSDPX (17.50). ICBAX return over 5 years is better than : 29.88 vs. FSDPX (4.75).
FSDPXICBAXFSDPX / ICBAX
Total Expense Ratio0.691.5644%
Annual Report Gross Expense Ratio0.691.5644%
Fund Existence40 years16 years-
Gain YTD11.67822.17953%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets824M140M589%
Annual Yield % from dividends1.300.72181%
Returns for 1 year17.5038.8045%
Returns for 3 years14.7437.9839%
Returns for 5 years4.7529.8816%
Returns for 10 years49.5488.8456%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
REREX65.48N/A
N/A
American Funds EUPAC R4
FIVLX15.07N/A
N/A
Fidelity International Value
PHLAX34.87N/A
N/A
PGIM Jennison Health Sciences A
DLQIX15.32N/A
N/A
BNY Mellon Large Cap Equity I
SCOBX48.39N/A
N/A
DWS International Opportunities S